Moderate Weight Loss May Be Way to Lower Breast Cancer Risk For Overweight ... - Cancer Network
Telegraph.
Prescription Errors are Tough to Swallow - InjuryBoard.com
Prescription Errors are Tough to SwallowInjuryBoard.
DARA BioSciences Paves Foundation for Growth - Equities.com
DARA BioSciences Paves Foundation for GrowthEquities.
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - MarketWatch (press release)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayMarketWatch (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .